Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-10T07:08:24.219Z Has data issue: false hasContentIssue false

Spaces for mood care: prevention and intervention in digital, community and health systems

Published online by Cambridge University Press:  01 February 2018

Rights & Permissions [Opens in a new window]

Abstract

Type
From the Editor's desk
Copyright
Copyright © The Royal College of Psychiatrists 2018 

Depression accounts for 4.4% of the global burden of disease.Reference Chisholm, Sanderson, Ayuso-Mateos and Saxena1, Reference Scott and Dickey2 Mood disorders more generally, including bipolar disorders, emotional dysregulation, mood and anxiety disorders, and mood disorders due to or caused by medical illness account for even more disability, poor general health and costs to the individual, carers and families, and society. Advances in aetiological and care-related research for depression can help identify effective care approaches for psychiatric and medical illnesses more generally. For example, depressed mood may also be a marker for, and potential mediating mechanism of, the physiological processes that lead to later-life dementia (see Schmitz et al, pp. 96–102); associations with other chronic medical conditions such as diabetes, heart and lung disease, and cancer make for an even greater impact on quality of life and functioning and mortality.Reference Thomson3Reference Delgado6

People with affective disorders may use a variety of methods to regulate their moods, including the use of psychoactive substances and self-treatment with alcohol, with associated harmful consequences including dementia. Alcohol-related dementia is not well researched, visible or a preventive priority (see Rao & Draper, pp. 67–68). Community-based interventions show promise in the treatment of common mental disorders (see Williams et al, pp. 88–95; Delgadillo, pp. 65–66) and hold some preventive value.

There is now a greater emphasis on digital interventions for mental illness and poor mental health (see Janse et al, pp. 112–118);Reference Hollis, Falconer, Martin, Whittington, Stockton and Glazebrook7Reference Gilbert9 digital interventions are promising as they extend the reach of care to people who feel stigmatised and avoid help-seeking. They can improve confidence, self-efficacy and empowerment; yet such approaches may seem risky if those with the most severe mental illnesses are expected to rely on technology-based self-management rather than careful and skilled assessment and personalised therapeutics. We need both types of care approaches. For example, for those with severe psychosis with associated impaired function, social isolation, worry, depression and a lack of motivation and suicidal thinking. People with immediate distress wish to see a skilled professional for urgent and reliable longer-term care, and their preference it seems is to see the same clinician whether as an in-patient or out-patient (see Bird et al, pp. 81–87). When mental illnesses are not responding to conventional and well-established treatments, innovations are needed for care in health services, but also in school-, work-based and population venues with the twin aims of preventing illness and promoting recovery from an established illness. Singing is good for you. Singing improves confidence, respiratory regulation, performance skills, emotional activation and social support; this month, we report that it seems to be helpful for postnatal depression (Fancourt & Perkins, pp. 119–121), the treatment of which also improves the health of children of mothers with depression.Reference Gonzalez, Moraes, Sosa, Umpierrez, Duarte and Cal10

Treatment-resistant depression is a most worrisome condition, not least because the fear, worry and misery experienced by people is compounded as people become even more hopeless when treatments are not working. BJPsych is calling for original research on treatment-resistant mood disorders (see http://bit.ly/2DmdkrV). This reflects the relative neglect of a common and disabling group of illnesses that remain poorly understood. Electroconvulsive therapy (ECT) is still a recommended element of the care pathway for depression that is not responding to other treatments or where there is some life-threatening urgency. It is still stigmatised, but clearly helpful for some people. Severe depression in elderly people and in individuals with depression with psychosis appears to show the best response to ECT. This has driven a search for new approaches such as ketamineReference Sanacora, Frye, McDonald, Mathew, Turner and Schatzberg11Reference McGirr, Berlim, Bond, Chan, Yatham and Lam13 and even opiates.Reference Stoll and Rueter14 Scherrer et al (pp. 103–111) show that treatment of depression with antidepressants leads to a reduction in the use of opiates being used for chronic pain, suggesting opiates may not be helpful. The studies linking mood disorders to other chronic conditions and drug use show that knowledge about the causes and treatments for mood disorders are needed for all health practitioners, not just in the mental health system, and in public health campaigns.

The Psychiatry Ashes

It is with great pleasure that I announce that the 2018 Psychiatry Ashes are underway, and full details will follow in the journal next month. If you simply cannot wait to hear more, please see our opponent's January issue.Reference Malhi and Bhui15

References

1Chisholm, D, Sanderson, K, Ayuso-Mateos, JL, Saxena, S. Reducing the global burden of depression: population-level analysis of intervention cost-effectiveness in 14 world regions. Br J Psychiatry 2004; 184: 393403.Google Scholar
2Scott, J, Dickey, B. Global burden of depression: the intersection of culture and medicine. Br J Psychiatry 2003; 183: 92–4.Google Scholar
3Thomson, W. Lifting the shroud on depression and premature mortality: a 49-year follow-up study. J Affect Disord 2011; 130: 60–5.Google Scholar
4Laursen, TM, Munk-Olsen, T, Nordentoft, M, Mortensen, PB. Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 2007; 68: 899907.Google Scholar
5Hayes, JF, Miles, J, Walters, K, King, M, Osborn, DP. A systematic review and meta-analysis of premature mortality in bipolar affective disorder. Acta Psychiatr Scand 2015; 131: 417–25.Google Scholar
6Delgado, M. Critique of a systematic review and meta-analysis of premature mortality in bipolar affective disorder. Acta Psychiatr Scand 2015; 132: 315.Google Scholar
7Hollis, C, Falconer, CJ, Martin, JL, Whittington, C, Stockton, S, Glazebrook, C, et al. Annual research review: digital health interventions for children and young people with mental health problems - a systematic and meta-review. J Child Psychol Psychiatry 2017; 58: 474503.Google Scholar
8Luik, AI, Bostock, S, Chisnall, L, Kyle, SD, Lidbetter, N, Baldwin, N, et al. Treating depression and anxiety with digital cognitive behavioural therapy for insomnia: a real world NHS evaluation using standardized outcome measures. Behav Cogn Psychother 2017; 45: 91–6.Google Scholar
9Gilbert, D. Patient commentary: online screening for depression-old (paternalistic) wine in new (digital) bottles. BMJ 2017; 358: j4207.Google Scholar
10Gonzalez, G, Moraes, M, Sosa, C, Umpierrez, E, Duarte, M, Cal, J et al. Maternal postnatal depression and its impact on child neurodevelopment: a cohort study [in Spanish]. Rev Chil Pediatr 2017; 88: 360–6.Google Scholar
11Sanacora, G, Frye, MA, McDonald, W, Mathew, SJ, Turner, MS, Schatzberg, AF, et al. A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry 2017; 74: 399405.Google Scholar
12Schoevers, RA, Chaves, TV, Balukova, SM, Rot, MA, Kortekaas, R. Oral ketamine for the treatment of pain and treatment-resistant depression. Br J Psychiatry 2016; 208: 108–13.Google Scholar
13McGirr, A, Berlim, MT, Bond, DJ, Chan, PY, Yatham, LN, Lam, RW. Adjunctive ketamine in electroconvulsive therapy: updated systematic review and meta-analysis. Br J Psychiatry 2017; 210: 403–7.Google Scholar
14Stoll, AL, Rueter, S. Treatment augmentation with opiates in severe and refractory major depression. Am J Psychiatry 1999; 156: 2017.Google Scholar
15Malhi, GS, Bhui, K. Ashes to Ashes. Aust N Z J Psychiatry 2018; 52: 79.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.